Source: MJ Freeway Press Release – 11-7-14
LAS VEGAS, Nov. 7, 2014 (GLOBE NEWSWIRE) — GrowBLOX Sciences, Inc., “GB Sciences” (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize our safe and consistent medicinal cannabis, has joined forces with cannabis industry enterprise software leader MJ Freeway to develop a breakthrough app which will enhance the medical cannabis patient experience. The free downloadable software will empower patients to register, make purchases, schedule pickup orders and—where available—request delivery of GB Sciences products.
“This innovative software solution will empower patients to interact with us at any time and from any place using their mobile devices,” said Craig Ellins, CEO of GB Sciences, Inc. “We are very excited to work with MJ Freeway, the leader in the cannabis enterprise software space.”
Integrated with MJ Freeway’s pioneering cannabis software and hardware solution, the app will facilitate the collection of symptom and product information to support GB Sciences’ research and development endeavors.
“We are constantly expanding the capabilities of our platform and solutions,” said MJ Freeway cofounder Amy Poinsett. “With the explosive growth in both the marijuana industry and the mobile web, it is critical that we offer our dispensary and retail customers the ability to communicate with their mobile customers.
“We are excited to be able to integrate our platform with this mobile app in conjunction with GB Sciences, a company with a passionate commitment for elevating product and service standards in this marketplace.”
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., “GB Sciences” (OTCQB:GBLX)—is a biopharmaceutical research and development company focused on creating safe, standardized pharmaceutical-grade cannabis-based therapies that target a variety of medical conditions. The company is pioneering technology, industry-leading processes, and big data-driven clinical research and development loop ability to bring relief to patients in communities across the country.
To learn more about GB Sciences, Inc., go to www.gbsciences.com.
About MJ Freeway
MJ Freeway makes running a cannabis business easy with seed-to-sale tracking software that manages every plant, gram, and dollar. This industry-leading technology provides patent-pending inventory control and grow management applications for a precise chain of custody, with unlimited remote technical support. Guaranteed to meet any state tracking requirements, MJ Freeway is the solution for marijuana producers, processors, infused product manufacturers, and retailers.
To learn more about MJ Freeway, go to www.mjfreeway.com.
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company’s ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Media and Investor Relations Contact: Stephen Hart Hayden IR [email protected] 917-658-7878
Source: GlobeNewswire (November 7, 2014 – 5:59 AM EST)
News by QuoteMedia